Pharmacy: Direct Oral Anticoagulants: A Pharmacist’s Perspective
10.00
Online
Elective
Please select your state to enroll in this course
About the Course:
This course is for all pharmacists and pharmacist technicians with a need to better understand direct oral anticoagulants and the conditions that are best treated with these medications.

Learning Objectives
Upon completion of this course, the pharmacist and pharmacy technician should be able to:
  • Describe indications of use for direct oral anticoagulants.
  • Select the appropriate drug dose for patients started on a direct oral anticoagulant.
  • Recommend appropriate direct oral anticoagulant therapy based on patient characteristics.
  • Choose the most appropriate oral anticoagulant for patients in special populations.
  • Evaluate patient cases to recommend appropriate therapy for bleeding management for patients taking direct oral anticoagulants.
About the Author:
Brittany Reed, PharmD is a critical care pharmacist currently practicing in the neuroscience intensive care unit.  She attended West Virginia University for pharmacy school, where she graduated in 2014.  Thereafter, she completed two years of residency, a PGY1 in pharmacy practice and a PGY2 in critical care.  Both residency years were completed at Charleston Area Medical Center in Charleston, WV.  Professionally, she is also board certified in both pharmacotherapy and critical care.  

How to receive credit:
  • A minimum test score of 75 percent is needed to obtain a credit.

Activity Type - Knowledge-based

Target Audience - Pharmacists, Pharmacists Technicians


Disclosures:

  • Contact hours will be awarded through the expiration date.
  • You must score 75% or higher on the final exam and complete the course evaluation to pass this course and have your record of completion submitted through CPE Monitor and to the NABP.
  • Through our review process, Colibri Healthcare, LLC ensures that this course content is presented in a balanced, unbiased manner and is free from commercial influence. It is Colibri Healthcare, LLC's policy not to accept commercial support.
  • All persons involved in the planning and development of this course have disclosed no relevant financial relationships or other conflicts of interest related to the course content.

 

Want Unlimited CE? Become a Member

Direct Oral Anticoagulants: A Pharmacist’s Perspective

10.00
About the Course:
This course is for all pharmacists and pharmacist technicians with a need to better understand direct oral anticoagulants and the conditions that are best treated with these medications.

Learning Objectives
Upon completion of this course, the pharmacist and pharmacy technician should be able to:
  • Describe indications of use for direct oral anticoagulants.
  • Select the appropriate drug dose for patients started on a direct oral anticoagulant.
  • Recommend appropriate direct oral anticoagulant therapy based on patient characteristics.
  • Choose the most appropriate oral anticoagulant for patients in special populations.
  • Evaluate patient cases to recommend appropriate therapy for bleeding management for patients taking direct oral anticoagulants.
About the Author:
Brittany Reed, PharmD is a critical care pharmacist currently practicing in the neuroscience intensive care unit.  She attended West Virginia University for pharmacy school, where she graduated in 2014.  Thereafter, she completed two years of residency, a PGY1 in pharmacy practice and a PGY2 in critical care.  Both residency years were completed at Charleston Area Medical Center in Charleston, WV.  Professionally, she is also board certified in both pharmacotherapy and critical care.  

How to receive credit:
  • A minimum test score of 75 percent is needed to obtain a credit.

Activity Type - Knowledge-based

Target Audience - Pharmacists, Pharmacists Technicians


Disclosures:

  • Contact hours will be awarded through the expiration date.
  • You must score 75% or higher on the final exam and complete the course evaluation to pass this course and have your record of completion submitted through CPE Monitor and to the NABP.
  • Through our review process, Colibri Healthcare, LLC ensures that this course content is presented in a balanced, unbiased manner and is free from commercial influence. It is Colibri Healthcare, LLC's policy not to accept commercial support.
  • All persons involved in the planning and development of this course have disclosed no relevant financial relationships or other conflicts of interest related to the course content.